nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC1—Vinblastine—head and neck cancer	0.2	0.288	CbGbCtD
Ofloxacin—ABCC1—Docetaxel—head and neck cancer	0.165	0.237	CbGbCtD
Ofloxacin—ABCC2—Vinblastine—head and neck cancer	0.148	0.213	CbGbCtD
Ofloxacin—ABCC2—Docetaxel—head and neck cancer	0.122	0.176	CbGbCtD
Ofloxacin—CYP1A2—Fluorouracil—head and neck cancer	0.0596	0.0858	CbGbCtD
Ofloxacin—SLC22A4—glottis—head and neck cancer	0.0166	0.463	CbGeAlD
Ofloxacin—SLC22A4—larynx—head and neck cancer	0.00586	0.164	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.00242	0.317	CbGdCrCtD
Ofloxacin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.00237	0.311	CbGdCrCtD
Ofloxacin—ABCC1—hair follicle—head and neck cancer	0.00174	0.0487	CbGeAlD
Ofloxacin—SLC22A4—neck—head and neck cancer	0.00155	0.0434	CbGeAlD
Ofloxacin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.00152	0.2	CbGdCrCtD
Ofloxacin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.0013	0.171	CbGdCrCtD
Ofloxacin—ABCC1—parotid gland—head and neck cancer	0.000953	0.0266	CbGeAlD
Ofloxacin—SLC22A4—trachea—head and neck cancer	0.000935	0.0261	CbGeAlD
Ofloxacin—TOP2A—thyroid gland—head and neck cancer	0.000925	0.0258	CbGeAlD
Ofloxacin—TOP2A—G0 and Early G1—CCNA1—head and neck cancer	0.000842	0.0789	CbGpPWpGaD
Ofloxacin—SLC22A5—parotid gland—head and neck cancer	0.000838	0.0234	CbGeAlD
Ofloxacin—SLC22A5—saliva-secreting gland—head and neck cancer	0.000802	0.0224	CbGeAlD
Ofloxacin—TOP2A—Gastric Cancer Network 1—CCNA1—head and neck cancer	0.000748	0.07	CbGpPWpGaD
Ofloxacin—SLC22A4—thyroid gland—head and neck cancer	0.00074	0.0207	CbGeAlD
Ofloxacin—ABCC1—trachea—head and neck cancer	0.000704	0.0197	CbGeAlD
Ofloxacin—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00067	0.0627	CbGpPWpGaD
Ofloxacin—Candida infection—Docetaxel—head and neck cancer	0.000661	0.00263	CcSEcCtD
Ofloxacin—Ataxia—Fluorouracil—head and neck cancer	0.000655	0.0026	CcSEcCtD
Ofloxacin—Neuropathy—Docetaxel—head and neck cancer	0.00065	0.00258	CcSEcCtD
Ofloxacin—Alopecia—Vinblastine—head and neck cancer	0.000648	0.00258	CcSEcCtD
Ofloxacin—Dry skin—Fluorouracil—head and neck cancer	0.000638	0.00254	CcSEcCtD
Ofloxacin—Oesophagitis—Docetaxel—head and neck cancer	0.000633	0.00252	CcSEcCtD
Ofloxacin—Neoplasm—Docetaxel—head and neck cancer	0.000626	0.00249	CcSEcCtD
Ofloxacin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000623	0.00248	CcSEcCtD
Ofloxacin—Lightheadedness—Docetaxel—head and neck cancer	0.000619	0.00246	CcSEcCtD
Ofloxacin—SLC22A5—trachea—head and neck cancer	0.000619	0.0173	CbGeAlD
Ofloxacin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000616	0.00245	CcSEcCtD
Ofloxacin—Angiopathy—Hydroxyurea—head and neck cancer	0.000607	0.00241	CcSEcCtD
Ofloxacin—Dysphagia—Fluorouracil—head and neck cancer	0.000602	0.00239	CcSEcCtD
Ofloxacin—Sepsis—Docetaxel—head and neck cancer	0.000601	0.00239	CcSEcCtD
Ofloxacin—Chills—Hydroxyurea—head and neck cancer	0.0006	0.00239	CcSEcCtD
Ofloxacin—Eosinophilia—Fluorouracil—head and neck cancer	0.000596	0.00237	CcSEcCtD
Ofloxacin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000593	0.00236	CcSEcCtD
Ofloxacin—Alopecia—Hydroxyurea—head and neck cancer	0.000591	0.00235	CcSEcCtD
Ofloxacin—Anaemia—Vinblastine—head and neck cancer	0.00059	0.00235	CcSEcCtD
Ofloxacin—Angina pectoris—Fluorouracil—head and neck cancer	0.000586	0.00233	CcSEcCtD
Ofloxacin—Phlebitis—Docetaxel—head and neck cancer	0.000583	0.00232	CcSEcCtD
Ofloxacin—Erythema—Hydroxyurea—head and neck cancer	0.000582	0.00232	CcSEcCtD
Ofloxacin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00058	0.00231	CcSEcCtD
Ofloxacin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000578	0.0023	CcSEcCtD
Ofloxacin—Malaise—Vinblastine—head and neck cancer	0.000576	0.00229	CcSEcCtD
Ofloxacin—TOP2A—lymph node—head and neck cancer	0.000574	0.016	CbGeAlD
Ofloxacin—Vertigo—Vinblastine—head and neck cancer	0.000574	0.00228	CcSEcCtD
Ofloxacin—Leukopenia—Vinblastine—head and neck cancer	0.000572	0.00227	CcSEcCtD
Ofloxacin—Pancytopenia—Fluorouracil—head and neck cancer	0.000571	0.00227	CcSEcCtD
Ofloxacin—Swelling—Docetaxel—head and neck cancer	0.00057	0.00226	CcSEcCtD
Ofloxacin—Deafness—Docetaxel—head and neck cancer	0.000562	0.00223	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000559	0.00222	CcSEcCtD
Ofloxacin—Hepatic failure—Docetaxel—head and neck cancer	0.000559	0.00222	CcSEcCtD
Ofloxacin—ABCC1—thyroid gland—head and neck cancer	0.000557	0.0155	CbGeAlD
Ofloxacin—Hypertension—Vinblastine—head and neck cancer	0.000551	0.00219	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000549	0.00218	CcSEcCtD
Ofloxacin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00054	0.00215	CcSEcCtD
Ofloxacin—Pneumonia—Fluorouracil—head and neck cancer	0.00054	0.00215	CcSEcCtD
Ofloxacin—Anaemia—Hydroxyurea—head and neck cancer	0.000538	0.00214	CcSEcCtD
Ofloxacin—Discomfort—Vinblastine—head and neck cancer	0.000537	0.00214	CcSEcCtD
Ofloxacin—Hot flush—Docetaxel—head and neck cancer	0.000537	0.00214	CcSEcCtD
Ofloxacin—Infestation NOS—Fluorouracil—head and neck cancer	0.000536	0.00213	CcSEcCtD
Ofloxacin—Infestation—Fluorouracil—head and neck cancer	0.000536	0.00213	CcSEcCtD
Ofloxacin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000533	0.00212	CcSEcCtD
Ofloxacin—Visual disturbance—Docetaxel—head and neck cancer	0.00053	0.00211	CcSEcCtD
Ofloxacin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00053	0.00211	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000529	0.0021	CcSEcCtD
Ofloxacin—Renal impairment—Docetaxel—head and neck cancer	0.000528	0.0021	CcSEcCtD
Ofloxacin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000526	0.00209	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000526	0.00209	CcSEcCtD
Ofloxacin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000526	0.00209	CcSEcCtD
Ofloxacin—Malaise—Hydroxyurea—head and neck cancer	0.000525	0.00209	CcSEcCtD
Ofloxacin—Stomatitis—Fluorouracil—head and neck cancer	0.000523	0.00208	CcSEcCtD
Ofloxacin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000521	0.00207	CcSEcCtD
Ofloxacin—Leukopenia—Hydroxyurea—head and neck cancer	0.000521	0.00207	CcSEcCtD
Ofloxacin—Cardiac failure—Docetaxel—head and neck cancer	0.000515	0.00205	CcSEcCtD
Ofloxacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00051	0.00203	CcSEcCtD
Ofloxacin—Epistaxis—Fluorouracil—head and neck cancer	0.000506	0.00201	CcSEcCtD
Ofloxacin—Hyponatraemia—Docetaxel—head and neck cancer	0.000504	0.00201	CcSEcCtD
Ofloxacin—Sinusitis—Fluorouracil—head and neck cancer	0.000503	0.002	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000502	0.002	CcSEcCtD
Ofloxacin—Pain in extremity—Docetaxel—head and neck cancer	0.000502	0.002	CcSEcCtD
Ofloxacin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000501	0.00199	CcSEcCtD
Ofloxacin—Anorexia—Vinblastine—head and neck cancer	0.000497	0.00198	CcSEcCtD
Ofloxacin—Migraine—Docetaxel—head and neck cancer	0.000495	0.00197	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000492	0.00196	CcSEcCtD
Ofloxacin—Discomfort—Hydroxyurea—head and neck cancer	0.00049	0.00195	CcSEcCtD
Ofloxacin—SLC22A5—thyroid gland—head and neck cancer	0.00049	0.0137	CbGeAlD
Ofloxacin—Haemoglobin—Fluorouracil—head and neck cancer	0.000484	0.00192	CcSEcCtD
Ofloxacin—Rhinitis—Fluorouracil—head and neck cancer	0.000483	0.00192	CcSEcCtD
Ofloxacin—Haemorrhage—Fluorouracil—head and neck cancer	0.000482	0.00192	CcSEcCtD
Ofloxacin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000479	0.00191	CcSEcCtD
Ofloxacin—Pharyngitis—Fluorouracil—head and neck cancer	0.000478	0.0019	CcSEcCtD
Ofloxacin—Oedema—Hydroxyurea—head and neck cancer	0.000475	0.00189	CcSEcCtD
Ofloxacin—Ataxia—Docetaxel—head and neck cancer	0.000472	0.00188	CcSEcCtD
Ofloxacin—Infection—Hydroxyurea—head and neck cancer	0.000472	0.00188	CcSEcCtD
Ofloxacin—Paraesthesia—Vinblastine—head and neck cancer	0.000468	0.00186	CcSEcCtD
Ofloxacin—Dehydration—Docetaxel—head and neck cancer	0.000467	0.00186	CcSEcCtD
Ofloxacin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000466	0.00185	CcSEcCtD
Ofloxacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000465	0.00185	CcSEcCtD
Ofloxacin—Skin disorder—Hydroxyurea—head and neck cancer	0.000462	0.00184	CcSEcCtD
Ofloxacin—Dry skin—Docetaxel—head and neck cancer	0.000461	0.00183	CcSEcCtD
Ofloxacin—SLC22A4—lymph node—head and neck cancer	0.00046	0.0128	CbGeAlD
Ofloxacin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000459	0.00182	CcSEcCtD
Ofloxacin—Breast disorder—Docetaxel—head and neck cancer	0.000454	0.00181	CcSEcCtD
Ofloxacin—Anorexia—Hydroxyurea—head and neck cancer	0.000453	0.0018	CcSEcCtD
Ofloxacin—Decreased appetite—Vinblastine—head and neck cancer	0.000453	0.0018	CcSEcCtD
Ofloxacin—Cramp muscle—Docetaxel—head and neck cancer	0.000452	0.0018	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000452	0.0018	CcSEcCtD
Ofloxacin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000449	0.00179	CcSEcCtD
Ofloxacin—Pain—Vinblastine—head and neck cancer	0.000446	0.00177	CcSEcCtD
Ofloxacin—Constipation—Vinblastine—head and neck cancer	0.000446	0.00177	CcSEcCtD
Ofloxacin—CYP1A2—thyroid gland—head and neck cancer	0.000444	0.0124	CbGeAlD
Ofloxacin—Dysphagia—Docetaxel—head and neck cancer	0.000434	0.00173	CcSEcCtD
Ofloxacin—Arrhythmia—Fluorouracil—head and neck cancer	0.00043	0.00171	CcSEcCtD
Ofloxacin—Feeling abnormal—Vinblastine—head and neck cancer	0.00043	0.00171	CcSEcCtD
Ofloxacin—Bronchospasm—Docetaxel—head and neck cancer	0.000427	0.0017	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000426	0.00169	CcSEcCtD
Ofloxacin—Alopecia—Fluorouracil—head and neck cancer	0.000426	0.00169	CcSEcCtD
Ofloxacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000424	0.00169	CcSEcCtD
Ofloxacin—Angina pectoris—Docetaxel—head and neck cancer	0.000423	0.00168	CcSEcCtD
Ofloxacin—Somnolence—Hydroxyurea—head and neck cancer	0.000423	0.00168	CcSEcCtD
Ofloxacin—Erythema—Fluorouracil—head and neck cancer	0.000419	0.00167	CcSEcCtD
Ofloxacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000418	0.00166	CcSEcCtD
Ofloxacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000413	0.00164	CcSEcCtD
Ofloxacin—Pancytopenia—Docetaxel—head and neck cancer	0.000412	0.00164	CcSEcCtD
Ofloxacin—Abdominal pain—Vinblastine—head and neck cancer	0.000412	0.00164	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00041	0.00163	CcSEcCtD
Ofloxacin—Fatigue—Hydroxyurea—head and neck cancer	0.00041	0.00163	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.000409	0.0382	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000408	0.0381	CbGpPWpGaD
Ofloxacin—Pain—Hydroxyurea—head and neck cancer	0.000407	0.00162	CcSEcCtD
Ofloxacin—Constipation—Hydroxyurea—head and neck cancer	0.000407	0.00162	CcSEcCtD
Ofloxacin—Neutropenia—Docetaxel—head and neck cancer	0.000406	0.00161	CcSEcCtD
Ofloxacin—Vision blurred—Fluorouracil—head and neck cancer	0.000395	0.00157	CcSEcCtD
Ofloxacin—Weight decreased—Docetaxel—head and neck cancer	0.000393	0.00156	CcSEcCtD
Ofloxacin—ABCC2—lymph node—head and neck cancer	0.000393	0.011	CbGeAlD
Ofloxacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000392	0.00156	CcSEcCtD
Ofloxacin—Pneumonia—Docetaxel—head and neck cancer	0.000389	0.00155	CcSEcCtD
Ofloxacin—Anaemia—Fluorouracil—head and neck cancer	0.000388	0.00154	CcSEcCtD
Ofloxacin—Infestation—Docetaxel—head and neck cancer	0.000387	0.00154	CcSEcCtD
Ofloxacin—Infestation NOS—Docetaxel—head and neck cancer	0.000387	0.00154	CcSEcCtD
Ofloxacin—Hypersensitivity—Vinblastine—head and neck cancer	0.000384	0.00153	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000384	0.00153	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000382	0.00152	CcSEcCtD
Ofloxacin—Renal failure—Docetaxel—head and neck cancer	0.000381	0.00151	CcSEcCtD
Ofloxacin—Myocardial infarction—Docetaxel—head and neck cancer	0.00038	0.00151	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00038	0.00151	CcSEcCtD
Ofloxacin—Stomatitis—Docetaxel—head and neck cancer	0.000377	0.0015	CcSEcCtD
Ofloxacin—Jaundice—Docetaxel—head and neck cancer	0.000377	0.0015	CcSEcCtD
Ofloxacin—Conjunctivitis—Docetaxel—head and neck cancer	0.000376	0.0015	CcSEcCtD
Ofloxacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000376	0.00149	CcSEcCtD
Ofloxacin—Leukopenia—Fluorouracil—head and neck cancer	0.000375	0.00149	CcSEcCtD
Ofloxacin—Asthenia—Vinblastine—head and neck cancer	0.000374	0.00149	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000366	0.00146	CcSEcCtD
Ofloxacin—Epistaxis—Docetaxel—head and neck cancer	0.000365	0.00145	CcSEcCtD
Ofloxacin—Agranulocytosis—Docetaxel—head and neck cancer	0.000361	0.00144	CcSEcCtD
Ofloxacin—Chest pain—Fluorouracil—head and neck cancer	0.000357	0.00142	CcSEcCtD
Ofloxacin—Myalgia—Fluorouracil—head and neck cancer	0.000357	0.00142	CcSEcCtD
Ofloxacin—Diarrhoea—Vinblastine—head and neck cancer	0.000357	0.00142	CcSEcCtD
Ofloxacin—Discomfort—Fluorouracil—head and neck cancer	0.000353	0.0014	CcSEcCtD
Ofloxacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00035	0.00139	CcSEcCtD
Ofloxacin—Haemoglobin—Docetaxel—head and neck cancer	0.000349	0.00139	CcSEcCtD
Ofloxacin—Rhinitis—Docetaxel—head and neck cancer	0.000348	0.00139	CcSEcCtD
Ofloxacin—Haemorrhage—Docetaxel—head and neck cancer	0.000348	0.00138	CcSEcCtD
Ofloxacin—Hepatitis—Docetaxel—head and neck cancer	0.000348	0.00138	CcSEcCtD
Ofloxacin—ABCC1—lymph node—head and neck cancer	0.000346	0.00966	CbGeAlD
Ofloxacin—Hypoaesthesia—Docetaxel—head and neck cancer	0.000346	0.00138	CcSEcCtD
Ofloxacin—Confusional state—Fluorouracil—head and neck cancer	0.000345	0.00137	CcSEcCtD
Ofloxacin—Pharyngitis—Docetaxel—head and neck cancer	0.000345	0.00137	CcSEcCtD
Ofloxacin—Dizziness—Vinblastine—head and neck cancer	0.000345	0.00137	CcSEcCtD
Ofloxacin—Urinary tract disorder—Docetaxel—head and neck cancer	0.000343	0.00137	CcSEcCtD
Ofloxacin—Oedema peripheral—Docetaxel—head and neck cancer	0.000342	0.00136	CcSEcCtD
Ofloxacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000342	0.00136	CcSEcCtD
Ofloxacin—Oedema—Fluorouracil—head and neck cancer	0.000342	0.00136	CcSEcCtD
Ofloxacin—Connective tissue disorder—Docetaxel—head and neck cancer	0.000342	0.00136	CcSEcCtD
Ofloxacin—Asthenia—Hydroxyurea—head and neck cancer	0.000341	0.00136	CcSEcCtD
Ofloxacin—Urethral disorder—Docetaxel—head and neck cancer	0.000341	0.00136	CcSEcCtD
Ofloxacin—Infection—Fluorouracil—head and neck cancer	0.00034	0.00135	CcSEcCtD
Ofloxacin—Nervous system disorder—Fluorouracil—head and neck cancer	0.000336	0.00133	CcSEcCtD
Ofloxacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000335	0.00133	CcSEcCtD
Ofloxacin—Visual impairment—Docetaxel—head and neck cancer	0.000335	0.00133	CcSEcCtD
Ofloxacin—Tachycardia—Fluorouracil—head and neck cancer	0.000334	0.00133	CcSEcCtD
Ofloxacin—Vomiting—Vinblastine—head and neck cancer	0.000331	0.00132	CcSEcCtD
Ofloxacin—Erythema multiforme—Docetaxel—head and neck cancer	0.000329	0.00131	CcSEcCtD
Ofloxacin—Headache—Vinblastine—head and neck cancer	0.000327	0.0013	CcSEcCtD
Ofloxacin—Anorexia—Fluorouracil—head and neck cancer	0.000326	0.0013	CcSEcCtD
Ofloxacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000325	0.00129	CcSEcCtD
Ofloxacin—Eye disorder—Docetaxel—head and neck cancer	0.000325	0.00129	CcSEcCtD
Ofloxacin—Cardiac disorder—Docetaxel—head and neck cancer	0.000323	0.00128	CcSEcCtD
Ofloxacin—Flushing—Docetaxel—head and neck cancer	0.000323	0.00128	CcSEcCtD
Ofloxacin—Hypotension—Fluorouracil—head and neck cancer	0.00032	0.00127	CcSEcCtD
Ofloxacin—Angiopathy—Docetaxel—head and neck cancer	0.000315	0.00125	CcSEcCtD
Ofloxacin—Dizziness—Hydroxyurea—head and neck cancer	0.000314	0.00125	CcSEcCtD
Ofloxacin—Immune system disorder—Docetaxel—head and neck cancer	0.000314	0.00125	CcSEcCtD
Ofloxacin—Mediastinal disorder—Docetaxel—head and neck cancer	0.000313	0.00125	CcSEcCtD
Ofloxacin—Chills—Docetaxel—head and neck cancer	0.000312	0.00124	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000312	0.00124	CcSEcCtD
Ofloxacin—Arrhythmia—Docetaxel—head and neck cancer	0.000311	0.00123	CcSEcCtD
Ofloxacin—Nausea—Vinblastine—head and neck cancer	0.00031	0.00123	CcSEcCtD
Ofloxacin—Insomnia—Fluorouracil—head and neck cancer	0.000309	0.00123	CcSEcCtD
Ofloxacin—Paraesthesia—Fluorouracil—head and neck cancer	0.000307	0.00122	CcSEcCtD
Ofloxacin—Alopecia—Docetaxel—head and neck cancer	0.000307	0.00122	CcSEcCtD
Ofloxacin—Dyspnoea—Fluorouracil—head and neck cancer	0.000305	0.00121	CcSEcCtD
Ofloxacin—Mental disorder—Docetaxel—head and neck cancer	0.000305	0.00121	CcSEcCtD
Ofloxacin—SLC22A5—lymph node—head and neck cancer	0.000304	0.00849	CbGeAlD
Ofloxacin—Somnolence—Fluorouracil—head and neck cancer	0.000304	0.00121	CcSEcCtD
Ofloxacin—Erythema—Docetaxel—head and neck cancer	0.000303	0.0012	CcSEcCtD
Ofloxacin—Malnutrition—Docetaxel—head and neck cancer	0.000303	0.0012	CcSEcCtD
Ofloxacin—Vomiting—Hydroxyurea—head and neck cancer	0.000302	0.0012	CcSEcCtD
Ofloxacin—Dyspepsia—Fluorouracil—head and neck cancer	0.000301	0.0012	CcSEcCtD
Ofloxacin—Rash—Hydroxyurea—head and neck cancer	0.0003	0.00119	CcSEcCtD
Ofloxacin—Dermatitis—Hydroxyurea—head and neck cancer	0.000299	0.00119	CcSEcCtD
Ofloxacin—Headache—Hydroxyurea—head and neck cancer	0.000298	0.00118	CcSEcCtD
Ofloxacin—Decreased appetite—Fluorouracil—head and neck cancer	0.000297	0.00118	CcSEcCtD
Ofloxacin—Dysgeusia—Docetaxel—head and neck cancer	0.000296	0.00118	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000295	0.00117	CcSEcCtD
Ofloxacin—Back pain—Docetaxel—head and neck cancer	0.000293	0.00116	CcSEcCtD
Ofloxacin—Pain—Fluorouracil—head and neck cancer	0.000293	0.00116	CcSEcCtD
Ofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000292	0.0274	CbGpPWpGaD
Ofloxacin—Muscle spasms—Docetaxel—head and neck cancer	0.000291	0.00116	CcSEcCtD
Ofloxacin—Nausea—Hydroxyurea—head and neck cancer	0.000282	0.00112	CcSEcCtD
Ofloxacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000282	0.00112	CcSEcCtD
Ofloxacin—Anaemia—Docetaxel—head and neck cancer	0.00028	0.00111	CcSEcCtD
Ofloxacin—Urticaria—Fluorouracil—head and neck cancer	0.000272	0.00108	CcSEcCtD
Ofloxacin—Syncope—Docetaxel—head and neck cancer	0.000271	0.00108	CcSEcCtD
Ofloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—head and neck cancer	0.000271	0.0254	CbGpPWpGaD
Ofloxacin—Leukopenia—Docetaxel—head and neck cancer	0.000271	0.00108	CcSEcCtD
Ofloxacin—Body temperature increased—Fluorouracil—head and neck cancer	0.00027	0.00108	CcSEcCtD
Ofloxacin—Palpitations—Docetaxel—head and neck cancer	0.000267	0.00106	CcSEcCtD
Ofloxacin—Loss of consciousness—Docetaxel—head and neck cancer	0.000266	0.00106	CcSEcCtD
Ofloxacin—Cough—Docetaxel—head and neck cancer	0.000264	0.00105	CcSEcCtD
Ofloxacin—Hypertension—Docetaxel—head and neck cancer	0.000261	0.00104	CcSEcCtD
Ofloxacin—Arthralgia—Docetaxel—head and neck cancer	0.000258	0.00102	CcSEcCtD
Ofloxacin—Chest pain—Docetaxel—head and neck cancer	0.000258	0.00102	CcSEcCtD
Ofloxacin—Myalgia—Docetaxel—head and neck cancer	0.000258	0.00102	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000256	0.00102	CcSEcCtD
Ofloxacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000252	0.001	CcSEcCtD
Ofloxacin—Dry mouth—Docetaxel—head and neck cancer	0.000252	0.001	CcSEcCtD
Ofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000249	0.0233	CbGpPWpGaD
Ofloxacin—Confusional state—Docetaxel—head and neck cancer	0.000249	0.00099	CcSEcCtD
Ofloxacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000247	0.000982	CcSEcCtD
Ofloxacin—Oedema—Docetaxel—head and neck cancer	0.000247	0.000982	CcSEcCtD
Ofloxacin—Infection—Docetaxel—head and neck cancer	0.000245	0.000976	CcSEcCtD
Ofloxacin—Shock—Docetaxel—head and neck cancer	0.000243	0.000966	CcSEcCtD
Ofloxacin—Nervous system disorder—Docetaxel—head and neck cancer	0.000242	0.000963	CcSEcCtD
Ofloxacin—Pruritus—Fluorouracil—head and neck cancer	0.000242	0.000963	CcSEcCtD
Ofloxacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000242	0.000962	CcSEcCtD
Ofloxacin—Tachycardia—Docetaxel—head and neck cancer	0.000241	0.000958	CcSEcCtD
Ofloxacin—Skin disorder—Docetaxel—head and neck cancer	0.00024	0.000954	CcSEcCtD
Ofloxacin—Anorexia—Docetaxel—head and neck cancer	0.000235	0.000936	CcSEcCtD
Ofloxacin—Diarrhoea—Fluorouracil—head and neck cancer	0.000234	0.000931	CcSEcCtD
Ofloxacin—Hypotension—Docetaxel—head and neck cancer	0.000231	0.000918	CcSEcCtD
Ofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000227	0.0212	CbGpPWpGaD
Ofloxacin—Dizziness—Fluorouracil—head and neck cancer	0.000226	0.0009	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000225	0.000895	CcSEcCtD
Ofloxacin—Insomnia—Docetaxel—head and neck cancer	0.000223	0.000888	CcSEcCtD
Ofloxacin—Paraesthesia—Docetaxel—head and neck cancer	0.000222	0.000882	CcSEcCtD
Ofloxacin—Dyspnoea—Docetaxel—head and neck cancer	0.00022	0.000876	CcSEcCtD
Ofloxacin—Somnolence—Docetaxel—head and neck cancer	0.00022	0.000873	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000219	0.0205	CbGpPWpGaD
Ofloxacin—Vomiting—Fluorouracil—head and neck cancer	0.000218	0.000865	CcSEcCtD
Ofloxacin—Dyspepsia—Docetaxel—head and neck cancer	0.000217	0.000864	CcSEcCtD
Ofloxacin—Rash—Fluorouracil—head and neck cancer	0.000216	0.000858	CcSEcCtD
Ofloxacin—Dermatitis—Fluorouracil—head and neck cancer	0.000216	0.000857	CcSEcCtD
Ofloxacin—Decreased appetite—Docetaxel—head and neck cancer	0.000215	0.000854	CcSEcCtD
Ofloxacin—Headache—Fluorouracil—head and neck cancer	0.000214	0.000852	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000213	0.000848	CcSEcCtD
Ofloxacin—Fatigue—Docetaxel—head and neck cancer	0.000213	0.000847	CcSEcCtD
Ofloxacin—Pain—Docetaxel—head and neck cancer	0.000211	0.00084	CcSEcCtD
Ofloxacin—Constipation—Docetaxel—head and neck cancer	0.000211	0.00084	CcSEcCtD
Ofloxacin—Feeling abnormal—Docetaxel—head and neck cancer	0.000204	0.000809	CcSEcCtD
Ofloxacin—Nausea—Fluorouracil—head and neck cancer	0.000203	0.000808	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000202	0.000803	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—head and neck cancer	0.000195	0.0183	CbGpPWpGaD
Ofloxacin—Abdominal pain—Docetaxel—head and neck cancer	0.000195	0.000776	CcSEcCtD
Ofloxacin—Body temperature increased—Docetaxel—head and neck cancer	0.000195	0.000776	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.000184	0.0172	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Docetaxel—head and neck cancer	0.000182	0.000724	CcSEcCtD
Ofloxacin—Asthenia—Docetaxel—head and neck cancer	0.000177	0.000705	CcSEcCtD
Ofloxacin—Pruritus—Docetaxel—head and neck cancer	0.000175	0.000695	CcSEcCtD
Ofloxacin—Diarrhoea—Docetaxel—head and neck cancer	0.000169	0.000672	CcSEcCtD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000169	0.0158	CbGpPWpGaD
Ofloxacin—Dizziness—Docetaxel—head and neck cancer	0.000163	0.000649	CcSEcCtD
Ofloxacin—Vomiting—Docetaxel—head and neck cancer	0.000157	0.000624	CcSEcCtD
Ofloxacin—Rash—Docetaxel—head and neck cancer	0.000156	0.000619	CcSEcCtD
Ofloxacin—Dermatitis—Docetaxel—head and neck cancer	0.000156	0.000619	CcSEcCtD
Ofloxacin—Headache—Docetaxel—head and neck cancer	0.000155	0.000615	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—head and neck cancer	0.000154	0.0144	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000153	0.0143	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000153	0.0143	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000151	0.0142	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.00015	0.014	CbGpPWpGaD
Ofloxacin—Nausea—Docetaxel—head and neck cancer	0.000147	0.000583	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000146	0.0137	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—MAPK3—head and neck cancer	0.000146	0.0136	CbGpPWpGaD
Ofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000143	0.0134	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—MAPK1—head and neck cancer	0.000138	0.013	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000137	0.0129	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—head and neck cancer	0.000135	0.0127	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000133	0.0125	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.00013	0.0122	CbGpPWpGaD
Ofloxacin—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00012	0.0112	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFA—head and neck cancer	0.000118	0.0111	CbGpPWpGaD
Ofloxacin—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000115	0.0108	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—head and neck cancer	0.000114	0.0106	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000105	0.00987	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000102	0.00958	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.01e-05	0.00843	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	8.89e-05	0.00832	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	8.02e-05	0.00751	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.99e-05	0.00748	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	7.84e-05	0.00734	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	7.82e-05	0.00732	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.7e-05	0.0072	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	7.67e-05	0.00718	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	7.55e-05	0.00707	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCNA1—head and neck cancer	7.17e-05	0.00671	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	6.86e-05	0.00642	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	6.15e-05	0.00576	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	6.15e-05	0.00576	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	6.15e-05	0.00576	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	5.81e-05	0.00544	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.81e-05	0.00544	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	5.78e-05	0.00541	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RAD51—head and neck cancer	5.76e-05	0.00539	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	5.75e-05	0.00538	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.63e-05	0.00527	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.56e-05	0.00521	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.46e-05	0.00511	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	5.31e-05	0.00497	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	4.97e-05	0.00465	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.97e-05	0.00465	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UROD—head and neck cancer	4.96e-05	0.00464	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.91e-05	0.00459	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.69e-05	0.00439	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	4.57e-05	0.00428	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	4.51e-05	0.00422	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.45e-05	0.00417	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.03e-05	0.00377	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.02e-05	0.00377	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.88e-05	0.00364	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	3.87e-05	0.00362	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	3.86e-05	0.00361	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.85e-05	0.0036	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	3.73e-05	0.00349	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	3.66e-05	0.00342	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.51e-05	0.00328	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TYMS—head and neck cancer	3.46e-05	0.00324	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.42e-05	0.0032	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	3.39e-05	0.00317	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.32e-05	0.00311	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.16e-05	0.00296	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.16e-05	0.00296	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	2.88e-05	0.0027	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.74e-05	0.00256	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.65e-05	0.00248	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	2.59e-05	0.00243	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	2.59e-05	0.00243	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	2.59e-05	0.00243	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	2.54e-05	0.00238	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.26e-05	0.00211	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.24e-05	0.0021	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.23e-05	0.00208	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.19e-05	0.00205	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.16e-05	0.00203	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.14e-05	0.002	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.11e-05	0.00198	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.08e-05	0.00195	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NAT2—head and neck cancer	2.06e-05	0.00193	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.95e-05	0.00182	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UROD—head and neck cancer	1.88e-05	0.00176	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—DPYD—head and neck cancer	1.81e-05	0.00169	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—head and neck cancer	1.74e-05	0.00163	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—YAP1—head and neck cancer	1.71e-05	0.0016	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.61e-05	0.0015	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.53e-05	0.00143	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.46e-05	0.00137	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	1.44e-05	0.00134	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	1.37e-05	0.00128	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.29e-05	0.0012	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—head and neck cancer	1.15e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.12e-05	0.00105	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TYMS—head and neck cancer	1.03e-05	0.000963	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—head and neck cancer	1.02e-05	0.000952	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX1—head and neck cancer	9.74e-06	0.000912	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1A1—head and neck cancer	9.64e-06	0.000902	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOTCH1—head and neck cancer	9.22e-06	0.000863	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.3e-06	0.000777	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.22e-06	0.000769	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.92e-06	0.000741	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NAT2—head and neck cancer	7.82e-06	0.000732	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—DPYD—head and neck cancer	6.86e-06	0.000642	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—head and neck cancer	6.84e-06	0.000641	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—YAP1—head and neck cancer	6.51e-06	0.000609	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—head and neck cancer	5.97e-06	0.000559	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—head and neck cancer	5.73e-06	0.000537	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—head and neck cancer	5.34e-06	0.0005	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—head and neck cancer	5.1e-06	0.000477	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—head and neck cancer	5e-06	0.000468	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.89e-06	0.000458	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK1—head and neck cancer	4.85e-06	0.000454	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—head and neck cancer	4.85e-06	0.000454	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.26e-06	0.000399	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—head and neck cancer	4.21e-06	0.000394	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TYMS—head and neck cancer	3.91e-06	0.000366	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—head and neck cancer	3.9e-06	0.000365	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.86e-06	0.000361	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX1—head and neck cancer	3.7e-06	0.000346	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.66e-06	0.000343	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—head and neck cancer	3.53e-06	0.00033	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—head and neck cancer	3.44e-06	0.000322	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.01e-06	0.000282	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—head and neck cancer	2.88e-06	0.00027	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.18e-06	0.000204	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—head and neck cancer	1.9e-06	0.000178	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.34e-06	0.000125	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.09e-06	0.000102	CbGpPWpGaD
